首页   按字顺浏览 期刊浏览 卷期浏览 Trimethoprim/Sulfamethoxazole Remains Active Against Enterotoxigenic Escherichia co...
Trimethoprim/Sulfamethoxazole Remains Active Against Enterotoxigenic Escherichia coli and Shigella Species in Guadalajara, Mexico

 

作者: JUAN BANDRES,   JOHN MATHEWSON,   CHARLES ERICSSON,   HERBERT DUPONT,  

 

期刊: The American Journal of the Medical Sciences  (OVID Available online 1992)
卷期: Volume 303, issue 5  

页码: 289-291

 

ISSN:0002-9629

 

年代: 1992

 

出版商: OVID

 

关键词: Travelers' diarrhea;Therapy;Mexico;Aztreonam;Fluoroquinolones;Trimethoprim/sulfamethoxazole

 

数据来源: OVID

 

摘要:

Bacterial isolates obtained from fecal cultures of U.S. adults in Guadalajara, Mexico, with diarrhea developing during the summers of 1987, 1988, and 1989 were tested for in vitro antimicrobial susceptibility. No resistance was seen among 220 enterotoxigenicEscherichia coliisolates nor among 89Shigellastrains to aztreonam, norfloxacin, ciprofloxacin, gentamicin, or furazolidone. High level (>1000 µg/ml) resistance to trimethoprim/sulfamethoxazole (TMP/SMX) was found in 7% ofE. coliand 3% ofShigellastrains. Susceptibility patterns of 27E. colistrains derived from fecal cultures of Mexican infants in Guadalajara with diarrhea during the same time period showed similar results, possibly reflecting the presence of a common microbial reservoir. The study serves as a baseline for newer antimicrobials (fluoroquinolones and aztreonam) where no resistance is currently seen and provides evidence of the continuing value of TMP/SMX for therapy of diarrhea among travelers to Guadalajara and perhaps other areas of Mexico.

 

点击下载:  PDF (319KB)



返 回